Avricore Health (AVCRF) Income from Continuing Operations (2013 - 2025)
Avricore Health (AVCRF) reported Income from Continuing Operations of 271448.31 for Q3 2025, down 111.85% year-over-year from 2290795.34 in Q3 2024, and up 19.86% quarter-over-quarter from 338704.01 in Q2 2025.
Avricore Health (AVCRF) Income from Continuing Operations (2013 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 13 years of Income from Continuing Operations data on file, last reported at 271448.31 in Q3 2025.
- Income from Continuing Operations for Q3 2025 came in at 271448.31, down 111.85% year-over-year; the trailing twelve-month figure through Sep 2025 was 790618.47 (down 1093.29% YoY), and the FY2025 annual result was 981497.42, down 1141.68% from the prior year.
- Income from Continuing Operations improved to 271448.31 in Q3 2025 per AVCRF's latest filing, from 338704.01 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 117616.78 in Q1 2024 and troughed at 338704.01 in Q2 2025.
- A 5-year average of 94216.85 and a median of 101505.22 in 2021 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations tumbled 1832.59% in 2022, then jumped 165.79% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 32138.04 in 2021, then slumped by 447.19% to 175856.15 in 2022, then jumped by 128.68% to 50442.76 in 2023, then slumped by 354.02% to 128132.6 in 2024, then tumbled by 111.85% to 271448.31 in 2025.
- Business Quant data shows AVCRF's Income from Continuing Operations at 271448.31 in Q3 2025, 338704.01 in Q2 2025, and 52333.55 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -271,448.31 |
| Jun 30, 2025 | -338,704.01 |
| Mar 31, 2025 | -52,333.55 |
| Sep 30, 2024 | -128,132.60 |
| Jun 30, 2024 | 39,668.76 |
| Mar 31, 2024 | 117,616.78 |
| Dec 31, 2023 | 50,442.76 |
| Sep 30, 2023 | -210,435.94 |
| Jun 30, 2023 | -209,758.42 |
| Mar 31, 2023 | 96,529.64 |
| Dec 31, 2022 | -175,856.15 |
| Sep 30, 2022 | -136,269.98 |
| Jun 30, 2022 | -162,509.11 |
| Mar 31, 2022 | -146,723.21 |
| Dec 31, 2021 | -32,138.04 |
| Sep 30, 2021 | -74,877.84 |
| Jun 30, 2021 | -53,382.03 |
| Mar 31, 2021 | -7,592.06 |
| Dec 31, 2020 | -231,313.00 |
| Sep 30, 2020 | 23,100.29 |